
Heidelberg Pharma AG
XETRA:HPHA

Heidelberg Pharma AG?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
2.17
3.12
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Heidelberg Pharma AG hold over its rivals?
What risks and challenges
does Heidelberg Pharma AG face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Heidelberg Pharma AG.
Provide an overview of the primary business activities
of Heidelberg Pharma AG.
What unique competitive advantages
does Heidelberg Pharma AG hold over its rivals?
What risks and challenges
does Heidelberg Pharma AG face in the near future?
Has there been any significant insider trading activity
in Heidelberg Pharma AG recently?
Summarize the latest earnings call
of Heidelberg Pharma AG.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Heidelberg Pharma AG.
Provide P/S
for Heidelberg Pharma AG.
Provide P/E
for Heidelberg Pharma AG.
Provide P/OCF
for Heidelberg Pharma AG.
Provide P/FCFE
for Heidelberg Pharma AG.
Provide P/B
for Heidelberg Pharma AG.
Provide EV/S
for Heidelberg Pharma AG.
Provide EV/GP
for Heidelberg Pharma AG.
Provide EV/EBITDA
for Heidelberg Pharma AG.
Provide EV/EBIT
for Heidelberg Pharma AG.
Provide EV/OCF
for Heidelberg Pharma AG.
Provide EV/FCFF
for Heidelberg Pharma AG.
Provide EV/IC
for Heidelberg Pharma AG.
Show me price targets
for Heidelberg Pharma AG made by professional analysts.
What are the Revenue projections
for Heidelberg Pharma AG?
How accurate were the past Revenue estimates
for Heidelberg Pharma AG?
What are the Net Income projections
for Heidelberg Pharma AG?
How accurate were the past Net Income estimates
for Heidelberg Pharma AG?
What are the EPS projections
for Heidelberg Pharma AG?
How accurate were the past EPS estimates
for Heidelberg Pharma AG?
What are the EBIT projections
for Heidelberg Pharma AG?
How accurate were the past EBIT estimates
for Heidelberg Pharma AG?
Compare the revenue forecasts
for Heidelberg Pharma AG with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Heidelberg Pharma AG and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Heidelberg Pharma AG against its competitors.
Analyze the profit margins
(gross, operating, and net) of Heidelberg Pharma AG compared to its peers.
Compare the P/E ratios
of Heidelberg Pharma AG against its peers.
Discuss the investment returns and shareholder value creation
comparing Heidelberg Pharma AG with its peers.
Analyze the financial leverage
of Heidelberg Pharma AG compared to its main competitors.
Show all profitability ratios
for Heidelberg Pharma AG.
Provide ROE
for Heidelberg Pharma AG.
Provide ROA
for Heidelberg Pharma AG.
Provide ROIC
for Heidelberg Pharma AG.
Provide ROCE
for Heidelberg Pharma AG.
Provide Gross Margin
for Heidelberg Pharma AG.
Provide Operating Margin
for Heidelberg Pharma AG.
Provide Net Margin
for Heidelberg Pharma AG.
Provide FCF Margin
for Heidelberg Pharma AG.
Show all solvency ratios
for Heidelberg Pharma AG.
Provide D/E Ratio
for Heidelberg Pharma AG.
Provide D/A Ratio
for Heidelberg Pharma AG.
Provide Interest Coverage Ratio
for Heidelberg Pharma AG.
Provide Altman Z-Score Ratio
for Heidelberg Pharma AG.
Provide Quick Ratio
for Heidelberg Pharma AG.
Provide Current Ratio
for Heidelberg Pharma AG.
Provide Cash Ratio
for Heidelberg Pharma AG.
What is the historical Revenue growth
over the last 5 years for Heidelberg Pharma AG?
What is the historical Net Income growth
over the last 5 years for Heidelberg Pharma AG?
What is the current Free Cash Flow
of Heidelberg Pharma AG?
Discuss the annual earnings per share (EPS)
trend over the past five years for Heidelberg Pharma AG.
P/E
Price to Earnings
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
Market Cap | P/E | ||||
---|---|---|---|---|---|
DE |
![]() |
Heidelberg Pharma AG
XETRA:HPHA
|
123m EUR | -6.6 | |
FR |
![]() |
Pharnext SCA
OTC:PNEXF
|
6T USD | -174 554.5 |
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
369.2B USD | 87.1 |
|
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
168.8B USD | 41.3 |
|
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
133B USD | 277.1 |
|
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
131.5B USD | -245.5 |
|
US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | -489.5 |
|
AU |
![]() |
CSL Ltd
ASX:CSL
|
124.3B AUD | 28.4 |
|
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
72.4B USD | 16.4 |
|
US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | -56.7 |
|
US |
![]() |
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
37.6B USD | -135.1 |
|
Earnings Growth | PEG | |||||
---|---|---|---|---|---|---|
DE |
![]() |
Heidelberg Pharma AG
XETRA:HPHA
|
Average P/E:
90.1
|
N/A | N/A | |
FR |
![]() |
Pharnext SCA
OTC:PNEXF
|
Negative Multiple: -174 554.5 | N/A | N/A |
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
87.1
|
88%
|
1 |
|
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
41.3
|
44%
|
0.9 |
|
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
277.1
|
185%
|
1.5 |
|
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Negative Multiple: -245.5 | N/A | N/A |
|
US |
E
|
Epizyme Inc
F:EPE
|
Negative Multiple: -489.5 | N/A | N/A |
|
AU |
![]() |
CSL Ltd
ASX:CSL
|
28.4
|
16%
|
1.8 |
|
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
16.4
|
11%
|
1.5 |
|
US |
S
|
Seagen Inc
F:SGT
|
Negative Multiple: -56.7 | N/A | N/A |
|
US |
![]() |
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
Negative Multiple: -135.1 | N/A | N/A |
|
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.